Biodesix reports strong Q2 revenue growth

Biodesix reports strong Q2 revenue growth

Biodesix Inc. (Nasdaq: BDSX), a Louisville-based diagnostic solutions company, reported strong revenue growth in the second quarter, but its loss was higher than analyst expectations. Biodesix recorded revenue of $20 million in Q2, up 12% from $17.9 million for the same period a year ago. The company reported a net loss of $11.47 million, or 8 cents per share, compared with $10.8 million, or 8 cents per share, in the second quarter of 2024. The …